• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪氨酸羟化酶作为神经黑色素合成关键酶的作用及神经黑色素与帕金森病的关系。

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.

机构信息

Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan.

Department of Physiological Chemistry, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.

出版信息

J Neural Transm (Vienna). 2023 May;130(5):611-625. doi: 10.1007/s00702-023-02617-6. Epub 2023 Mar 20.

DOI:10.1007/s00702-023-02617-6
PMID:36939908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10121510/
Abstract

The dark pigment neuromelanin (NM) is abundant in cell bodies of dopamine (DA) neurons in the substantia nigra (SN) and norepinephrine (NE) neurons in the locus coeruleus (LC) in the human brain. During the progression of Parkinson's disease (PD), together with the degeneration of the respective catecholamine (CA) neurons, the NM levels in the SN and LC markedly decrease. However, questions remain among others on how NM is associated with PD and how it is synthesized. The biosynthesis pathway of NM in the human brain has been controversial because the presence of tyrosinase in CA neurons in the SN and LC has been elusive. We propose the following NM synthesis pathway in these CA neurons: (1) Tyrosine is converted by tyrosine hydroxylase (TH) to L-3,4-dihydroxyphenylalanine (L-DOPA), which is converted by aromatic L-amino acid decarboxylase to DA, which in LC neurons is converted by dopamine β-hydroxylase to NE; (2) DA or NE is autoxidized to dopamine quinone (DAQ) or norepinephrine quinone (NEQ); and (3) DAQ or NEQ is converted to eumelanic NM (euNM) and pheomelanic NM (pheoNM) in the absence and presence of cysteine, respectively. This process involves proteins as cysteine source and iron. We also discuss whether the NM amounts per neuromelanin-positive (NM) CA neuron are higher in PD brain, whether NM quantitatively correlates with neurodegeneration, and whether an active lifestyle may reduce NM formation.

摘要

黑色素(NM)在人类大脑的黑质(SN)中的多巴胺(DA)神经元和蓝斑核(LC)中的去甲肾上腺素(NE)神经元的细胞体中含量丰富。在帕金森病(PD)的进展过程中,伴随着相应的儿茶酚胺(CA)神经元的退化,SN 和 LC 中的 NM 水平显著降低。然而,人们仍然存在一些疑问,例如 NM 如何与 PD 相关,以及它是如何合成的。由于在 SN 和 LC 的 CA 神经元中存在酪氨酸酶的存在一直难以捉摸,因此 NM 在人类大脑中的生物合成途径一直存在争议。我们提出了这些 CA 神经元中 NM 合成途径:(1)酪氨酸通过酪氨酸羟化酶(TH)转化为 L-3,4-二羟基苯丙氨酸(L-DOPA),L-DOPA 被芳香族 L-氨基酸脱羧酶转化为 DA,DA 在 LC 神经元中被多巴胺β-羟化酶转化为 NE;(2)DA 或 NE 自动氧化为多巴胺醌(DAQ)或去甲肾上腺素醌(NEQ);(3)DAQ 或 NEQ 在不存在和存在半胱氨酸的情况下分别转化为真黑色素(euNM)和褐黑色素(pheoNM)。这个过程涉及到作为半胱氨酸来源的蛋白质和铁。我们还讨论了 PD 大脑中每个 NM 阳性(NM)CA 神经元中的 NM 含量是否更高,NM 是否与神经退行性变定量相关,以及积极的生活方式是否可能减少 NM 的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/ae5bacc100b2/702_2023_2617_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/171e28528359/702_2023_2617_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/428e31cb10f2/702_2023_2617_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/ae5bacc100b2/702_2023_2617_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/171e28528359/702_2023_2617_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/428e31cb10f2/702_2023_2617_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/10121510/ae5bacc100b2/702_2023_2617_Fig3_HTML.jpg

相似文献

1
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.酪氨酸羟化酶作为神经黑色素合成关键酶的作用及神经黑色素与帕金森病的关系。
J Neural Transm (Vienna). 2023 May;130(5):611-625. doi: 10.1007/s00702-023-02617-6. Epub 2023 Mar 20.
2
Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.帕金森病中的神经黑色素:酪氨酸羟化酶和酪氨酸酶。
Int J Mol Sci. 2022 Apr 10;23(8):4176. doi: 10.3390/ijms23084176.
3
Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.儿茶酚胺与帕金森病:酪氨酸羟化酶(TH)对四氢生物蝶呤(BH4)和 GTP 环化水解酶 I(GCH1)对细胞因子、神经黑色素和基因治疗:历史概述。
J Neural Transm (Vienna). 2024 Jun;131(6):617-630. doi: 10.1007/s00702-023-02673-y. Epub 2023 Aug 28.
4
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus.去甲肾上腺素及其代谢产物参与了源自蓝斑的神经黑素的合成。
J Neurochem. 2015 Nov;135(4):768-76. doi: 10.1111/jnc.13237. Epub 2015 Sep 4.
5
Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.迷走神经刺激改善帕金森病模型中的运动和神经元群体。
Brain Stimul. 2017 Nov-Dec;10(6):1045-1054. doi: 10.1016/j.brs.2017.08.008. Epub 2017 Aug 24.
6
Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons.黑暗中的谜题:解析蓝斑核神经元中神经黑色素与神经退行性变的关系。
Neurosci Biobehav Rev. 2023 Sep;152:105287. doi: 10.1016/j.neubiorev.2023.105287. Epub 2023 Jun 15.
7
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.Cav1.3 通道通过 NCS-1 控制黑质多巴胺神经元中的 D2 自身受体反应。
Brain. 2014 Aug;137(Pt 8):2287-302. doi: 10.1093/brain/awu131. Epub 2014 Jun 16.
8
[Neuromelanin in neurons of substantia nigra lacking tyrosine hydroxylase].[黑质中缺乏酪氨酸羟化酶的神经元中的神经黑色素]
Morfologiia. 2012;141(2):65-7.
9
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.人类神经黑色素在大鼠黑质中诱发神经炎症和神经退行性变:对帕金森病的启示。
Acta Neuropathol. 2008 Jul;116(1):47-55. doi: 10.1007/s00401-008-0361-7. Epub 2008 Mar 15.
10
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease.在帕金森病的黑质神经黑色素中,多巴褐黑素增加。
Prog Neurobiol. 2023 Apr;223:102414. doi: 10.1016/j.pneurobio.2023.102414. Epub 2023 Feb 4.

引用本文的文献

1
Strabismus and nystagmus in oculocutaneous albinism: clinical perspectives, diagnosis, and role of neurotransmitters.眼皮肤白化病中的斜视和眼球震颤:临床观点、诊断及神经递质的作用
Neurogenetics. 2025 Jun 18;26(1):50. doi: 10.1007/s10048-025-00830-x.
2
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.左旋多巴治疗:贯穿帕金森病进展过程中的影响及机制。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.
3
Role of iron in brain development, aging, and neurodegenerative diseases.

本文引用的文献

1
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease.在帕金森病的黑质神经黑色素中,多巴褐黑素增加。
Prog Neurobiol. 2023 Apr;223:102414. doi: 10.1016/j.pneurobio.2023.102414. Epub 2023 Feb 4.
2
The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies.路易体痴呆症中神经黑色素颗粒的蛋白质组。
Cells. 2022 Nov 9;11(22):3538. doi: 10.3390/cells11223538.
3
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes.黑质神经黑色素颗粒:蛋白质组学图谱与酪氨酸羟化酶、应激颗粒和溶酶体相关。
铁在大脑发育、衰老及神经退行性疾病中的作用。
Ann Med. 2025 Dec;57(1):2472871. doi: 10.1080/07853890.2025.2472871. Epub 2025 Mar 4.
4
Design, Synthesis, and Anti-Melanogenic Activity of 2-Mercaptomethylbenzo[]imidazole Derivatives Serving as Tyrosinase Inhibitors: An In Silico, In Vitro, and In Vivo Exploration.作为酪氨酸酶抑制剂的2-巯基甲基苯并咪唑衍生物的设计、合成及抗黑色素生成活性:计算机模拟、体外及体内研究
Antioxidants (Basel). 2024 Oct 16;13(10):1248. doi: 10.3390/antiox13101248.
5
Skeletal muscle reprogramming enhances reinnervation after peripheral nerve injury.骨骼肌重编程增强周围神经损伤后的神经再支配。
Nat Commun. 2024 Oct 25;15(1):9218. doi: 10.1038/s41467-024-53276-4.
6
Inflammaging and Brain Aging.炎症与大脑衰老。
Int J Mol Sci. 2024 Sep 30;25(19):10535. doi: 10.3390/ijms251910535.
7
Estrogen-immuno-neuromodulation disorders in menopausal depression.男性更年期抑郁症的雌激素免疫神经调节障碍。
J Neuroinflammation. 2024 Jun 19;21(1):159. doi: 10.1186/s12974-024-03152-1.
8
Synergistic Biomedical Potential and Molecular Docking Analyses of Coumarin-Triazole Hybrids as Tyrosinase Inhibitors: Design, Synthesis, In Vitro Profiling, and In Silico Studies.香豆素-三唑杂化物作为酪氨酸酶抑制剂的协同生物医学潜力及分子对接分析:设计、合成、体外分析及计算机模拟研究
Pharmaceuticals (Basel). 2024 Apr 20;17(4):532. doi: 10.3390/ph17040532.
9
Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.帕金森病:细胞长期遭受多巴胺相关氧化应激和其他生物能量挑战的影响。
Int J Mol Sci. 2024 Feb 7;25(4):2009. doi: 10.3390/ijms25042009.
10
African Under-Utilized Medicinal Leafy Vegetables Studied by Microtiter Plate Assays and High-Performance Thin-Layer Chromatography-Planar Assays.采用微量滴定板分析和高效薄层色谱-平面分析研究非洲未充分利用的药用叶菜类植物。
Molecules. 2024 Feb 5;29(3):733. doi: 10.3390/molecules29030733.
J Neural Transm (Vienna). 2022 Oct;129(10):1257-1270. doi: 10.1007/s00702-022-02530-4. Epub 2022 Jul 19.
4
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role.脑老化和帕金森病中的神经黑色素:合成、结构、神经炎症和神经退行性作用。
IUBMB Life. 2023 Jan;75(1):55-65. doi: 10.1002/iub.2654. Epub 2022 Jun 11.
5
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus.去甲肾上腺素衍生的水溶性黑色素-蛋白-Fe/Cu 缀合物作为人蓝斑脑区神经黑色素的可靠模型。
Angew Chem Int Ed Engl. 2022 Aug 8;61(32):e202204787. doi: 10.1002/anie.202204787. Epub 2022 Jun 24.
6
Voluntary Exercise Boosts Striatal Dopamine Release: Evidence for the Necessary and Sufficient Role of BDNF.自愿运动促进纹状体多巴胺释放:BDNF 的必要和充分作用证据。
J Neurosci. 2022 Jun 8;42(23):4725-4736. doi: 10.1523/JNEUROSCI.2273-21.2022. Epub 2022 May 16.
7
Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.帕金森病中的神经黑色素:酪氨酸羟化酶和酪氨酸酶。
Int J Mol Sci. 2022 Apr 10;23(8):4176. doi: 10.3390/ijms23084176.
8
Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.结构机制酪氨酸羟化酶抑制多巴胺和再激活丝氨酸 40 磷酸化。
Nat Commun. 2022 Jan 10;13(1):74. doi: 10.1038/s41467-021-27657-y.
9
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.铁作为致病乐队中的首席演奏家,在散发性帕金森病中发挥作用。
J Neural Transm (Vienna). 2021 Oct;128(10):1577-1598. doi: 10.1007/s00702-021-02414-z. Epub 2021 Oct 12.
10
Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia.左旋多巴诱发异动症的病理生理机制及实验性药物治疗
J Exp Pharmacol. 2021 Apr 29;13:469-485. doi: 10.2147/JEP.S265282. eCollection 2021.